POSTERS A: Risk Factors| Volume 138, SUPPLEMENT 1, S95, October 2020

Does concomitant DCIS affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective

      Background: Ductal carcinoma in situ (DCIS) is an established precursor to invasive ductal carcinoma (IDC) and its coexistence with IDC appear to favour reduced biological aggressiveness. Its prognostic implication and ability to affect clinical outcome has been controversial with no prior Asian studies. This study aims to be the first to explore if concomitant DCIS affects the clinical behavior in terms of disease progression and overall survival among Asian patients with IDC.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect